
Loading, please wait...

Loading, please wait...

Private hospitals in Andhra Pradesh face a significant operational crisis. The Asha healthcare suspension of free services under the Dr NTR Vaidya Seva Trust began this Wednesday. This move follows the state government’s failure to clear pending dues worth Rs 3,000 crore. Consequently, poor patients may lose access to critical cashless treatment at specialty centers. The Andhra Pradesh Speciality Hospital Association (Asha) stated that survival is no longer possible without these funds.
The association claims the government ignored previous promises to release funds by last December. Instead, arrears continued to mount over the last three months. Many hospitals now struggle to maintain daily operations without these vital payments. Therefore, they cannot sustain the corporate-level care promised under the state scheme. Because of this financial gap, medical providers feel forced to stop services to prevent further debt. Asha has appealed to the public to support their agitation during this difficult period.
Asha also criticized the proposed Universal Health Scheme (UHS). They question the feasibility of a new program when old debts remain unpaid. Furthermore, the association objects to using outdated 2017 rates for new service packages. They argue that inflation and rising medical costs make these rates impossible to implement today. Unfortunately, the government has not included private hospitals in the UHS design process. This lack of collaboration creates additional friction between the state and healthcare providers.
Q1: Why did Asha suspend services under the Dr NTR Vaidya Seva Trust?
Asha suspended services because the state government owes private network hospitals approximately Rs 3,000 crore in pending dues for cashless treatments provided to patients.
Q2: How does this suspension affect healthcare access?
The suspension means that poor patients relying on the Dr NTR Vaidya Seva scheme will no longer receive free specialty care at private network hospitals until the dues are settled.
Q3: What are the main objections to the new Universal Health Scheme?
Hospitals object to the implementation of the new scheme without clearing old debts and the use of 2017 reimbursement rates which do not reflect current medical costs.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Asha suspends free healthcare services under the Dr NTR Vaidya Seva scheme in Andhra Pradesh due to Rs 3,000 crore in unpaid government dues....
6 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday